Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sankyo accelerates antiangina drug development

Dec. 15, 1999

Optimal dose discerned for clinprost in arteriosclerosis obliterans

Dec. 14, 1999

Angiotensin II antagonists with isoquinoline structure discovered at Chinese university

Dec. 14, 1999

Selectus successfully completes phase IIb trial of beta-blocker

Dec. 14, 1999

HU-308: a potent and specific agonist at the peripheral cannabinoid receptor

Dec. 13, 1999

New cardiovascular gene therapy product appears to be safe in patients

Dec. 10, 1999

CV Therapeutics advances CVT-510 into phase II clinical trials

Dec. 10, 1999

Preparation and use of inhibitors of sodium-dependent Cl-/HCO3- exchange

Dec. 8, 1999

Chiron and Scios complete FGF agreement

Dec. 8, 1999

New cardioselective K(ATP) channel blocker inhibits ventricular fibrillation in ischemic rat model

Dec. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...